Brown Wealth Management’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$718K Hold
236,136
0.16% 69
2026
Q1
$727K Sell
236,136
-22,537
-9% -$95.7K 0.19% 66
2025
Q4
$934K Buy
258,673
+25,000
+11% +$109K 0.25% 57
2025
Q3
$881K Buy
233,673
+2,590
+1% +$10K 0.25% 58
2025
Q2
$894K Buy
231,083
+131,059
+131% +$709K 0.28% 53
2025
Q1
$500K Buy
100,024
+50,024
+100% +$317K 0.17% 59
2024
Q4
$361K Sell
50,000
-248
-0.5% -$1.9K 0.13% 62
2024
Q3
$309K Buy
50,248
+248
+0.5% +$1.68K 0.11% 65
2024
Q2
$333K Hold
50,000
0.13% 65
2024
Q1
$509K Sell
50,000
-25,000
-33% -$254K 0.21% 54
2023
Q4
$844K Buy
+75,000
New +$313K 0.37% 41

Other funds holding ALT

Brown Wealth Management's ALT Position: Q2 2026 in Review

Brown Wealth Management held its Altimmune (ALT) position steady in Q2 2026 at 236,136 shares worth $718K. The position accounts for 0.16% of the portfolio, ranked #69.

Brown Wealth Management first reported a position in ALT in Q4 2023 and has held it in 11 quarters since. The position peaked at $934K in Q4 2025. 14 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Brown Wealth Management held 236,136 shares of Altimmune worth $718K as of Q2 2026.
  • Brown Wealth Management left its Altimmune share count unchanged in Q2 2026.
  • Altimmune made up 0.16% of Brown Wealth Management's portfolio in Q2 2026, its #69 holding.
  • Brown Wealth Management first reported a position in Altimmune in Q4 2023 and has held it in 11 quarters since.
  • Brown Wealth Management's Altimmune position peaked at $934K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Brown Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.